These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10654322)

  • 1. Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis.
    Németh I; Túri S; Haszon I; Bereczki C
    Pediatr Nephrol; 2000 Jan; 14(1):13-7. PubMed ID: 10654322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure.
    Túri S; Németh I; Varga I; Bodrogi T; Matkovics B
    Pediatr Nephrol; 1992 Nov; 6(6):536-41. PubMed ID: 1482641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients.
    Usberti M; Gerardi G; Micheli A; Tira P; Bufano G; Gaggia P; Movilli E; Cancarini GC; De Marinis S; D'Avolio G; Broccoli R; Manganoni A; Albertin A; Di Lorenzo D
    J Nephrol; 2002; 15(5):558-64. PubMed ID: 12455724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid peroxidation and vitamin E in red blood cells and plasma in hemodialysis patients under rhEPO treatment.
    Nenov D; Paskalev D; Yankova T; Tchankova P
    Artif Organs; 1995 May; 19(5):436-9. PubMed ID: 7625923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E-bonded cellulose membrane, lipoperoxidation, and anemia in hemodialysis patients.
    Triolo L; Malaguti M; Ansali F; Comunian MC; Arcangeloni O; Coppolino F; Marrocco F; Sicoli R; Biagini M
    Artif Cells Blood Substit Immobil Biotechnol; 2003 May; 31(2):185-91. PubMed ID: 12751839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin prevents oxidative stress resulting from iron and erythropoietin administration.
    Herrera J; Nava M; Romero F; Rodríguez-Iturbe B
    Am J Kidney Dis; 2001 Apr; 37(4):750-7. PubMed ID: 11273875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early treatment of premature infants with recombinant human erythropoietin.
    Messer J; Haddad J; Donato L; Astruc D; Matis J
    Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy.
    Georgatzakou HT; Tzounakas VL; Kriebardis AG; Velentzas AD; Papageorgiou EG; Voulgaridou AI; Kokkalis AC; Antonelou MH; Papassideri IS
    Eur J Haematol; 2017 Jun; 98(6):590-600. PubMed ID: 28295628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of silymarin and vitamin E supplementation on oxidative stress markers, and hemoglobin levels among patients on hemodialysis.
    Roozbeh J; Shahriyari B; Akmali M; Vessal G; Pakfetrat M; Raees Jalali GA; Afshariani R; Hasheminasab M; Ghahramani N
    Ren Fail; 2011; 33(2):118-23. PubMed ID: 21332331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of vitamin E supplementation on erythropoietin responsiveness in chronic hemodialysis patients with low levels of erythrocyte superoxide dismutase.
    Rusu A; Rusu F; Zalutchi D; Muresan A; Gherman Caprioara M; Kacso I
    Int Urol Nephrol; 2013 Apr; 45(2):495-501. PubMed ID: 22528588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
    Panichi V; Rosati A; Paoletti S; Ferrandello P; Migliori M; Beati S; Bernabini G; Daini R; Casani A; Angelini D; Parrini M; Rossi A; Petrone I; Barsotti G; Donadio C; Donati G; Grazi G; Manca Rizza G; Garosi G; Sansoni E; Braccagni B; Sidoti A; Boracelli D; Biagioli M; Moriconi L; Finato V; Mannarino A; Grimaldi C; Pansa F; Imperiali P; Mura C; Bianchi S; Bigazzi R
    Blood Purif; 2011; 32(1):7-14. PubMed ID: 21242686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.
    Pascual J; Teruel JL; Moya JL; Liaño F; Jiménez-Mena M; Ortuño J
    Clin Nephrol; 1991 Jun; 35(6):280-7. PubMed ID: 1831414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis.
    Díez JJ; Iglesias P; Sastre J; Aguilera A; Bajo MA; Méndez J; Gómez Pan A; Selgas R
    Metabolism; 1999 Feb; 48(2):210-6. PubMed ID: 10024084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of renal anemia with recombinant human erythropoietin].
    Burghard R; Gordjani N; Leititis JU
    Monatsschr Kinderheilkd; 1989 Mar; 137(3):174-7. PubMed ID: 2716749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative damage to RBC membranes and pentose phosphate shunt activity in hemodialysis patients after suspension of erythropoietin treatment.
    Taccone-Galluci M; Lubrano R; Trapasso E; Clerico A; Latorre P; Meloni C; Morosetti M; Castello MA; Casciani CU
    ASAIO J; 1994; 40(3):M663-6. PubMed ID: 8555597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide and glutathione status in erythrocytes of children undergoing chronic hemodialysis under erythropoietin treatment.
    Sachs G; Siems W; Grune T; Schmidt G; Gerber G; Zoellner K
    Biomed Biochim Acta; 1990; 49(2-3):S123-4. PubMed ID: 2386496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative damage during hemodialysis using a vitamin-E-modified dialysis membrane: a preliminary characterization.
    Buoncristiani U; Galli F; Rovidati S; Albertini MC; Campus G; Canestrari F
    Nephron; 1997; 77(1):57-61. PubMed ID: 9380239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced coagulation and fibrinolysis during treatment with recombinant human erythropoietin in patients undergoing chronic hemodialysis.
    Tomura S; Nakamura Y; Tachibana K; Deguchi F; Ando R; Chida Y; Marumo F
    Blood Purif; 1993; 11(6):370-7. PubMed ID: 8043258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
    Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
    Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral L-carnitine does not decrease erythropoietin requirement in pediatric dialysis.
    Lilien MR; Duran M; Quak JM; Frankhuisen JJ; Schröder CH
    Pediatr Nephrol; 2000 Nov; 15(1-2):17-20. PubMed ID: 11095004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.